newsfilter
← Latest News
GlobeNewswire·

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Expects to enroll first patient in Phase 2 LOTUS Trial of AVTX-009 in hidradenitis suppurativa in the second half of 2024Appointed Dr. Mittie Doyle as Chief Medical Officer and Paul Varki as Chief Legal OfficerCash on